Back

PRIME Education, Inc. (PRIME®)

  • Carcinoma, Non-Small-Cell Lung
  • Immunotherapy

Targeted and Immunotherapy-Based Combination Approaches in Advanced NSCLC: Second-Line and Beyond

Treatment options for advanced NSCLC in the second line and later setting continue to expand, with targeted agents and immunotherapy combinations offering new opportunities for improved outcomes. This interactive Booster Quiz will challenge you to apply biomarker-driven strategies for treatment selection and sequencing using the latest clinical evidence. Receive expert feedback in real time and take away a clear summary of the supporting data to optimize outcomes beyond first line.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AAPA Category 1 Credit™Up to 0.25 creditsAMA PRA Category 1 Credit™Up to 0.25 creditsNursingUp to 0.25 creditsPharmacyUp to 0.25 credits

MOC types

No MOC

FDA REMS

No

Qualifies for MIPS

No

Pricing

Free

Reported to ACCME by the provider

  • Enduring / On-demand
  • Credit · Up to 0.25 credits
  • Commercial Support
  • Released
    Oct 30, 2025
  • Last day to claim credit
    Oct 30, 2026 3 weeks left